Engineered for Adaptability
Vaxess’ GMP facility was built to flexibly accommodate a range of future molecules. The line was built to support rapid movement of new products into Phase I and II trials.
Full-scale Manufacturing
With support from BARDA, Vaxess has full engineering drawings, costs, and lead times for 25M and 100M patch/year manufacturing facilities.